Beta
Company data is growing.
← All companies
/
Top lists
/
Insmed
Insmed
2016–2025 · 469 US lab companies
2026-08-05
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
Millions
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
—
—
10
136
164
188
245
305
364
606
Operating profit (EBIT)
−173
−189
−307
−235
−265
−375
−457
−710
−878
−1 247
Net income attributable to shareholders
−176
−193
−324
−254
−294
−435
−482
−750
−914
−1 277
Gross margin
—
—
75,4%
82,3%
75,8%
76,6%
77,5%
78,5%
76,4%
79,7%
Operating cash flow
−147
−160
−258
−251
−219
−363
−400
−536
−684
−935
Free cash flow
−151
−163
−271
−293
−226
−372
−410
−550
−706
−968
Cash
163
381
495
487
533
717
1 074
482
555
510
−1 500
−1 000
−500
0
500
1 000
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
10
136
164
188
245
305
364
606
−173
−189
−307
−235
−265
−375
−457
−710
−878
−1 247